SATSUMA PHARMACEUTICALS, INC. (STSA) Social Stream
SATSUMA PHARMACEUTICALS INC (STSA) Price Targets From Analysts
Use the tables below to see what analysts covering SATSUMA PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-12 | 3 | $15 | $5 | $11.666 | $1.07 | 990.28% |
| 2022-08-10 | 2 | $15 | $5 | $11 | $1.07 | 928.04% |
| 2022-08-31 | 3 | $16 | $5 | $12.25 | $1.07 | 1044.86% |
| 2022-09-21 | 3 | $18 | $5 | $13 | $1.07 | 1114.95% |
| 2022-11-07 | 4 | $18 | $13 | $15.5 | $1.07 | 1348.6% |
| 2022-11-15 | 3 | $3 | $1 | $2.333 | $1.07 | 118.04% |
| 2023-03-30 | 4 | $3 | $1 | $2.333 | $1.07 | 118.04% |
| 2023-05-19 | 4 | $3 | $1 | $2 | $1.07 | 86.92% |
The Trend in the Analyst Price Target
Over the past 21 months, STSA's average price target has gone down $9.67.
Over the past 47 weeks, STSA's average upside potential has been 185.02%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-21 | 3 | 15 | 5 | 11.000 | 3.070 | 258.31% |
| 2022-08-10 | 3 | 15 | 5 | 11.000 | 6.000 | 83.33% |
| 2022-11-15 | 3 | 3 | 1 | 2.333 | 0.627 | 272.09% |
| 2022-11-15 | 4 | 3 | 1 | 2.333 | 0.627 | 272.09% |
| 2023-05-19 | 4 | 3 | 1 | 2.000 | 1.060 | 88.68% |
STSA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.5 | 1 | 0 | 3 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 14 months, STSA's average broker recommendation rating worsened by 0.83.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for STSA as an investment opportunity.
- SATSUMA PHARMACEUTICALS INC's average analyst price target is greater than 109.1% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, SATSUMA PHARMACEUTICALS INC's number of analysts covering the stock is higher than 114.57% of them.
- STSA has a greater upside potential (average analyst target price relative to current price) than 984.72% of all US stocks.
- In terms of how SATSUMA PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -712.48% of that group.
In the Pharmaceutical Products industry, MIRM, FULC, and BCEL are the three stocks most similar to SATSUMA PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding STSA using the data that counts. Try POWR Ratings for free.